Is it time to Buy before this week’s earning report Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH)

0
133

Earnings results for Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH)

Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingJun 2020 , the consensus EPS* forecast has remained the same over the past week at -0.14 and remained the same over the past month at -0.14. none raised and none lowered their forecast. For the fiscal year ending Dec 2020 , the consensus EPS* forecast has remained the same over the past week at -0.6 and remained the same over the past month at -0.6 . none raised and none lowered their forecast.

Hoth Therapeutics last released its earnings results on August 13th, 2020. The reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by $0.06. Hoth Therapeutics has generated $0.00 earnings per share over the last year. Hoth Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, August 19th, 2020 based off prior year’s report dates.

Analyst Opinion on Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH)

1 Wall Street analysts have issued ratings and price targets for Hoth Therapeutics in the last 12 months. Their average twelve-month price target is $10.00, predicting that the stock has a possible upside of 259.71%. The high price target for HOTH is $10.00 and the low price target for HOTH is $10.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of “Hold.”

Hoth Therapeutics has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $10.00, Hoth Therapeutics has a forecasted upside of 259.7% from its current price of $2.78. Hoth Therapeutics has received no research coverage in the past 90 days.

Dividend Strength: Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH)

Hoth Therapeutics does not currently pay a dividend. Hoth Therapeutics does not have a long track record of dividend growth.

Insiders buying/selling: Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH)

In the past three months, Hoth Therapeutics insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $500,000.00 in company stock. Only 17.27% of the stock of Hoth Therapeutics is held by insiders. Only 0.24% of the stock of Hoth Therapeutics is held by institutions.

Earnings and Valuation of Hoth Therapeutics Stock Forecast, Price & News (NASDAQ:HOTH

Hoth Therapeutics has a P/B Ratio of 11.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here